The U.S. Food and Drug Administration (FDA) will host a webinar to share information and answer questions about the COVID-19 Transition Guidances for Medical Devices: Transition Plan for Medical Devices That Fall Within Enforcement Policies Issued During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency and Transition Plan for Medical Devices Issued Emergency Use Authorizations (EUAs) Related to Coronavirus Disease 2019 (COVID-19).

• Date: Tuesday, April 18, 2023 
• Time: 1:00 – 2:30 p.m. ET 
• Registration: No registration required. View webinar details for call-in information. 

During this webinar, the FDA will: 

• Help prepare manufacturers and other stakeholders for the orderly and transparent transition to normal operations. 
• Describe recommendations regarding submitting a marketing submission and the timeline for doing so. 
• Provide examples to illustrate the transition policies and exemplify the 180-day transition period timeline. 
• Answer your questions about the guidances on the COVID-19 transition plans. 

April 26 Town Hall for COVID-19 Laboratory and Test Developers 

In addition to the April 18 webinar, the FDA will host a separate town hall about the COVID-19 transition guidances for laboratory and test developers.